Should Orthotopic Heart Transplantation Using Marginal Donors Be Limited to Higher Volume Centers?
Arman Kilic(College of Charleston), John V. Conte(Commonwealth Medical College), Eric S. Weiss(University of Pittsburgh), David D. Yuh(Johns Hopkins University), Jeremiah G. Allen(Johns Hopkins University), Timothy J. George(Johns Hopkins University), Ashish S. Shah(Vanderbilt University Medical Center)
Cited by 37
Related Papers
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients
|Journal of the American College of Cardiology|2010|583
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
|Blood|2018|402
Transplantation Outcomes with Donor Hearts after Circulatory Death
|New England Journal of Medicine|2023|328
Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy
|European Heart Journal|2009|251